Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New IRAK-4/FLT-3 inhibitors identified at PharmaBlock Sciences

Sep. 9, 2021

[44Sc]Sc-B28110 shows preclinical promise as a radiotracer for the imaging of prostate cancer

Sep. 8, 2021

Mebendazole slows progression and metastasis in pancreatic cancer

Sep. 8, 2021

Bristol Myers Squibb patents rotein-arginine deiminase type-4 inhibitors

Sep. 8, 2021

Bahcesehir University presents new apoptosis regulator Bcl-2 inhibitors

Sep. 8, 2021

ZEN-3694 reverses acquired resistance to CDK4/6 inhibitors in ER+ breast cancer

Sep. 7, 2021

Monoglyceride lipase inhibitors identified at Janssen

Sep. 7, 2021

New cytochrome P450 1B1 inhibitors identfied at the University of Kentucky

Sep. 6, 2021

University of Minho chromene compound induces apoptosis in breast cancer cells

Sep. 6, 2021

Shanghai Meiyue Biotech Development divulges transcription factor PU.1 inhibitors

Sep. 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.